NPPB and hydrops fetalis: Many prognostic biomarkers, including natriuretic peptide (B‐type natriuretic peptide [BNP] and N‐terminal pro brain natriuretic peptide [NT‐proBNP]) have been well‐studied in HF patients, but their clinical application is limited due to challenges in risk stratification.7